You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
歌禮制藥-B(01672.HK)獲執行董事兼控股股東增持231.1萬股
格隆匯 10-17 18:04

格隆匯10月17日丨歌禮制藥-B(01672.HK)公佈,董事會獲公司執行董事兼控股股東吳勁梓及何淨島告知,彼等共同以總代價698.66萬港元(相當於均價每股3.02港元)在公開市場上購買合共231.1萬股公司股份。

緊隨此次購買後,吳勁梓及何淨島於合共599,532,078股股份中擁有權益,約佔截至公告日期公司已發行股本總額的53.50%。

此次購買充分顯示了控股股東對公司整體發展前景及增長潛力充滿信心,包括實現公司2019年的目標,即銷售、醫保準入、研發,以及引進、收購處於臨牀階段和已商業化的項目,同時進一步提升公司財務業績表現。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account